CLS Holdings USA, Inc. focuses on the extraction and conversion of cannabinoids in the United States. The company extracts various cannabinoids from the marijuana plant and converts into concentrates, such as oils, waxes, edibles, and shatters. Its concentrates are used for electronic cigarettes vaporization, and pharmaceutical and other purposes. The company also offers consulting services to cannabis-related businesses comprising growers, dispensaries, and laboratories. CLS Holdings USA, Inc. was founded in 2014 and is based in Miami, Florida.
Industry, Sector and Symbol
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone888-438-9132
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
CLS Holdings USA (OTCMKTS:CLSH) Frequently Asked Questions
What is CLS Holdings USA's stock symbol?
CLS Holdings USA trades on the OTCMKTS under the ticker symbol "CLSH."
What is the consensus analysts' recommendation for CLS Holdings USA?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CLS Holdings USA in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CLS Holdings USA.
Has CLS Holdings USA been receiving favorable news coverage?
News headlines about CLSH stock have trended somewhat negative on Wednesday, according to InfoTrie. The research firm identifies negative and positive news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. CLS Holdings USA earned a media sentiment score of -1.5 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for CLS Holdings USA.
Who are some of CLS Holdings USA's key competitors?
Some companies that are related to CLS Holdings USA include 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Applied Biosciences (APPB), Biome Grow (BIO), Blueberries Medical (BBM), Cannabis Science (CBIS), Cannara Biotech (LOVE), Cansortium (CNTMF), Charlotte's Web (CWBHF), Choom (CHOOF), Cipher Pharmaceuticals (CPHRF), Cosmos (COSM) and Curaleaf (CURLF).
What other stocks do shareholders of CLS Holdings USA own?
Who are CLS Holdings USA's key executives?
CLS Holdings USA's management team includes the folowing people:
- Mr. Jeffrey I. Binder, Chairman & CEO (Age 72)
- Mr. Andrew J. Glashow, Pres, COO & Director (Age 56)
- Mr. Frank J. Tarantino, Chief Financial Officer (Age 60)
- Mr. Benjamin J. Sillitoe, Chief Exec. Officer of Oasis Cannabis (Age 42)
- Mr. Don Decatur, Chief Operating Officer of CLS Nevada, Inc. (Age 35)
How do I buy shares of CLS Holdings USA?
Shares of CLSH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is CLS Holdings USA's stock price today?
One share of CLSH stock can currently be purchased for approximately $0.2599.
What is CLS Holdings USA's official website?
How can I contact CLS Holdings USA?
The company can be reached via phone at 888-438-9132.
MarketBeat Community Rating for CLS Holdings USA (OTCMKTS CLSH)
MarketBeat's community ratings are surveys of what our community members think about CLS Holdings USA and other stocks. Vote "Outperform" if you believe CLSH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLSH will underperform the S&P 500 over the long term. You may vote once every thirty days.
